These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 17699197

  • 21. Late conversion from calcineurin inhibitor-based to sirolimus-based immunosuppression due to chronic toxicity: a prospective study with protocol biopsy amendment.
    Uslu A, Töz H, Sen S, Alkan FT, Nart A, Aykas A, Doğan M, Postaci H, Sahin T, Simşek C.
    Transplant Proc; 2009 Mar; 41(2):756-63. PubMed ID: 19328973
    [Abstract] [Full Text] [Related]

  • 22. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP, Pascoe MD, Alberu J, del Carmen Rial M, Oberbauer R, Brennan DC, Campistol JM, Racusen L, Polinsky MS, Goldberg-Alberts R, Li H, Scarola J, Neylan JF, Sirolimus CONVERT Trial Study Group.
    Transplantation; 2009 Jan 27; 87(2):233-42. PubMed ID: 19155978
    [Abstract] [Full Text] [Related]

  • 23. High sirolimus levels may induce focal segmental glomerulosclerosis de novo.
    Letavernier E, Bruneval P, Mandet C, Duong Van Huyen JP, Péraldi MN, Helal I, Noël LH, Legendre C.
    Clin J Am Soc Nephrol; 2007 Mar 27; 2(2):326-33. PubMed ID: 17699432
    [Abstract] [Full Text] [Related]

  • 24. Recurrence of focal segmental glomerulosclerosis after renal transplantation: a case report.
    Akash N.
    Saudi J Kidney Dis Transpl; 2007 Mar 27; 18(1):91-4. PubMed ID: 17237899
    [Abstract] [Full Text] [Related]

  • 25. Cyclosporine-based immunosuppressive therapy for patients with steroid-resistant focal segmental glomerulosclerosis: a meta-analysis.
    Chiou YY, Lee YC, Chen MJ.
    Curr Med Res Opin; 2017 Aug 27; 33(8):1389-1399. PubMed ID: 28436233
    [Abstract] [Full Text] [Related]

  • 26. [Primary focal segmental glomerulosclerosis in adults: response to treatment and outcome].
    Niang A, Hachim K, Zahiri K, Fatihi E, Benghanem M, Ramdani B, Sqalli S, Zaid D.
    Dakar Med; 2004 Aug 27; 49(1):13-6. PubMed ID: 15782470
    [Abstract] [Full Text] [Related]

  • 27. Expression of synaptopodin and GLEPP1 as markers of steroid responsiveness in primary focal segmental glomerulosclerosis.
    Hirakawa M, Tsuruya K, Yotsueda H, Tokumoto M, Ikeda H, Katafuchi R, Fujimi S, Hirakata H, Iida M.
    Life Sci; 2006 Jul 17; 79(8):757-63. PubMed ID: 16564554
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Choosing the right treatment approach in focal and segmental glomerular sclerosis with chronic renal failure].
    Valerio F, Sottini L, Turina S, Dallera N, Faberi E, Kenou R, Mazzola G, Scolari F.
    G Ital Nefrol; 2008 Jul 17; 25 Suppl 44():S88-S98. PubMed ID: 19048592
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency.
    Yang YJ, Chen DZ, Li LX, Kou JT, Lang R, Jin ZK, Han DD, He Q.
    Transplant Proc; 2008 Jun 17; 40(5):1541-4. PubMed ID: 18589147
    [Abstract] [Full Text] [Related]

  • 35. Focal segmental glomerulosclerosis in mild IgA nephropathy: a clinical-pathologic study.
    Weber CL, Rose CL, Magil AB.
    Nephrol Dial Transplant; 2009 Feb 17; 24(2):483-8. PubMed ID: 18786972
    [Abstract] [Full Text] [Related]

  • 36. Renoprotective effects of sirolimus in non-immune initiated focal segmental glomerulosclerosis.
    Rangan GK, Coombes JD.
    Nephrol Dial Transplant; 2007 Aug 17; 22(8):2175-82. PubMed ID: 17550925
    [Abstract] [Full Text] [Related]

  • 37. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
    Peters HP, van de Kar NC, Wetzels JF.
    Neth J Med; 2008 Nov 17; 66(10):408-15. PubMed ID: 19011266
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Morphometric and immunohistochemical insight into focal segmental glomerulosclerosis in obese and non-obese patients.
    Danilewicz M, Wagrowska-Danielwicz M.
    Nefrologia; 2009 Nov 17; 29(1):35-41. PubMed ID: 19240770
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.